Inhalation delivery resulted in significantly better survival of rats with the highly aggressive, EGFR mutant, H1975-derived lung tumors and the tumor burden of the moderately growing, KRAS mutant, A549-derived lung tumors. This evidence concerns the gene KRAS and neoplasm.